News

Cover Montana has helped 50,000 people — especially low-income earners, the uninsured, Native Americans and pregnant or new ...
US PHARMACEUTICAL giant Merck & Co plans to cut around 6,000 jobs, mirroring similar cost-saving measures among rival drug ...
Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...
Known officially as XFG, the variant was first detected in Southeast Asia back in January. For months, it flew under the ...
Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that that fell short of analyst expectations. Revenue declined 41% to $142m, ...
Global vaccine giants have begun large-scale workforce reductions. U.S. Moderna announced it will cut approximately 10% of its workforce, while Merck (MSD) announced an 8% reduction. This is in ...
Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that that fell short of analyst expectations. Revenue declined 41% to ...
More than 800 Moderna employees will lose their jobs this year as costs are slashed Former COVID-vaccine darling announces job cuts a day before quarterly results are set for release.
Breaking News Moderna to Cut 10% of Global Workforce To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.
Moderna’s MRNA-8.06%decrease; red down pointing triangle second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening demand for its Covid-19 ...
Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening demand for its Covid-19 vaccine.
Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce.